Overview

A Study Using fMRI Imaging to Evaluate the Effect of NKTR-181 on Brain Activity in Healthy, Non-physically Dependent Recreational Opioid Users.

Status:
Terminated

Trial end date:
2020-01-03

Target enrollment:

Participant gender:

Summary

The main purpose of this study is to evaluate the effect of NKTR-181 on brain activity in healthy, non-physically dependent recreational opioid users. This study will last about 88 days for each participant.

Phase:

Phase 1

Details

Lead Sponsor:

Nektar Therapeutics

Treatments:

Oxycodone